Have your own idea? Try our Stock Screener
U.K. (FTSE) Life Sciences Industry Analysis
UpdatedJun 03, 2026
DataAggregated Company Financials
Companies7
- 7D1.5%
- 3M8.0%
- 1Y11.5%
- YTD6.7%
In the last week, the Life Sciences industry is up 1.5%, with Oxford Nanopore Technologies up 2.2%. In the last 12 months, the industry was up 12%. As for the next few years, earnings are expected to grow by 57% per annum.
Industry Valuation and Performance
Has the U.K. Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 03 Jun 2026 | UK£1.5b | UK£323.0m | -UK£166,018,254.00 | 1265.7x | -9.3x | 4.8x |
| Fri, 01 May 2026 | UK£1.3b | UK£318.2m | -UK£167,469,254.00 | n/a | -7.9x | 4.2x |
| Sun, 29 Mar 2026 | UK£1.3b | UK£324.0m | -UK£161,423,254.00 | 8.4x | -8.2x | 4.1x |
| Tue, 24 Feb 2026 | UK£1.5b | UK£304.7m | -UK£159,511,254.00 | 11.8x | -9.5x | 4.9x |
| Thu, 22 Jan 2026 | UK£1.8b | UK£304.6m | -UK£159,441,254.00 | 7.1x | -11.2x | 5.9x |
| Sat, 20 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 9.5x | -8.9x | 4.7x |
| Mon, 17 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 8.2x | -9.1x | 4.9x |
| Wed, 15 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 10.1x | -9.8x | 5.3x |
| Fri, 12 Sep 2025 | UK£1.9b | UK£313.5m | -UK£158,190,352.00 | 6.2x | -11.8x | 6x |
| Sun, 10 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.9x | -14.3x | 7.9x |
| Tue, 08 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.6x | -9.8x | 5.4x |
| Thu, 05 Jun 2025 | UK£1.6b | UK£319.4m | -UK£190,791,730.00 | 6.6x | -8.1x | 4.9x |
| Sat, 03 May 2025 | UK£1.7b | UK£314.0m | -UK£192,459,514.70 | 11.3x | -8.7x | 5.3x |
| Mon, 31 Mar 2025 | UK£1.5b | UK£315.7m | -UK£186,460,928.95 | 5.5x | -7.9x | 4.7x |
| Wed, 26 Feb 2025 | UK£1.6b | UK£306.4m | -UK£195,093,302.64 | 6.2x | -8.4x | 5.3x |
| Fri, 24 Jan 2025 | UK£2.1b | UK£307.2m | -UK£195,788,725.20 | 7.7x | -10.6x | 6.8x |
| Sun, 22 Dec 2024 | UK£2.0b | UK£306.6m | -UK£195,263,763.36 | 7.7x | -10.2x | 6.5x |
| Tue, 19 Nov 2024 | UK£1.8b | UK£305.8m | -UK£193,578,219.28 | 9.9x | -9.2x | 5.8x |
| Thu, 17 Oct 2024 | UK£2.0b | UK£304.6m | -UK£192,522,726.70 | 11.5x | -10.4x | 6.6x |
| Sat, 14 Sep 2024 | UK£2.0b | UK£301.9m | -UK£190,970,145.50 | 11x | -10.6x | 6.7x |
| Mon, 12 Aug 2024 | UK£1.8b | UK£296.8m | -UK£189,164,393.70 | 12.3x | -9.6x | 6.1x |
| Wed, 10 Jul 2024 | UK£1.5b | UK£295.6m | -UK£189,989,628.63 | 11.5x | -8.1x | 5.2x |
| Fri, 07 Jun 2024 | UK£1.6b | UK£295.5m | -UK£189,707,628.63 | 11.4x | -8.3x | 5.4x |
| Sun, 05 May 2024 | UK£1.6b | UK£292.8m | -UK£188,897,474.93 | 6902.8x | -8.3x | 5.3x |
| Tue, 02 Apr 2024 | UK£1.7b | UK£319.1m | -UK£191,419,403.70 | 69.8x | -9.1x | 5.5x |
| Thu, 29 Feb 2024 | UK£1.9b | UK£285.8m | -UK£189,230,023.72 | 6787x | -9.9x | 6.5x |
| Sat, 27 Jan 2024 | UK£2.7b | UK£450.2m | -UK£176,590,140.00 | 65.1x | -15.3x | 6x |
| Mon, 25 Dec 2023 | UK£3.1b | UK£450.0m | -UK£174,026,893.00 | 52.7x | -18.1x | 7x |
| Wed, 22 Nov 2023 | UK£3.0b | UK£455.6m | -UK£168,678,421.00 | 49.9x | -17.9x | 6.6x |
| Fri, 20 Oct 2023 | UK£3.1b | UK£458.7m | -UK£165,682,864.00 | 48.9x | -18.5x | 6.7x |
| Sun, 17 Sep 2023 | UK£3.1b | UK£440.6m | -UK£167,135,947.00 | 67.5x | -18.8x | 7.1x |
| Tue, 15 Aug 2023 | UK£3.2b | UK£476.2m | -UK£126,577,489.00 | 70.6x | -25.6x | 6.8x |
| Thu, 13 Jul 2023 | UK£3.1b | UK£475.9m | -UK£124,244,334.00 | 66.1x | -24.7x | 6.5x |
| Sat, 10 Jun 2023 | UK£3.2b | UK£476.9m | -UK£125,014,596.00 | 63.5x | -25.5x | 6.7x |
Price to Earnings Ratio
-25.5x
Current Industry PE
- Investors are pessimistic on the British Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.9x is higher than the industry's current PS ratio of 4.8x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -0.85% | |
| Healthcare | -5.24% | |
| Life Sciences | 1.51% | |
| Clinical Research and Equipment | 1.51% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONT Oxford Nanopore Technologies | UK£1.36 | 2.2% +UK£28.2m | 14.6% | PS5.9x | |
| GDR genedrive | UK£0.013 | 8.3% +UK£1.6m | -8.8% | PS17.8x | |
| HVO hVIVO | UK£0.083 | 1.9% +UK£1.0m | -20.7% | PS1.1x | |
| PYC Physiomics | UK£0.007 | 7.7% +UK£226.6k | 52.2% | PS3.1x |